Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Reviews. Cancer|March 21, 2002
Immune evasion in human papillomavirus-associated cervical cancerRobert W Tindle
Vaccine|June 5, 2007
Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccineKaren A Herd, Carsten Wiethe, Robert W Tindle
The Journal of General Virology|January 8, 2010
Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virusKaren A Herd, Michelle Nelson, Suresh Mahalingam, et al.
Immunology|August 3, 2002
Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 proteinMichael D Street, Tracy Doan, Karen A Herd, et al.
Cancer Immunology, Immunotherapy : CII|October 14, 2004
A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumourTracy Doan, Karen Herd, Ian Ramshaw, et al.
Virology|February 26, 2004
Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumourKaren A Herd, Tracey Harvey, Alexander A Khromykh, et al.
Immunology and Cell Biology|January 22, 2003
Generation of CTL responses using Kunjin replicon RNAScott M Ward, Robert W Tindle, Alexander A Khromykh, et al.
Journal of Virology|March 31, 2006
Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopesWai-Ping Woo, Tracy Doan, Karen A Herd, et al.
Virology|August 11, 2007
Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg) vaccine enhance CTL responses, but not tumor protectionOscar Haigh, Huayang Guo, Kristy Edgtton, et al.
The Journal of Infectious Diseases|February 5, 2008
Major histocompatibility complex class I cytotoxic T lymphocyte immunity to human metapneumovirus (hMPV) in individuals with previous hMPV infection and respiratory diseaseKaren A Herd, Michael D Nissen, Peter M Hopkins, et al.
Pageof 2